Novel Drugs Targeting Inflammatory Pathologies
Silkim Pharma has developed a novel, protected platform of drugs for proven treatments of multiple indications. The company's platform is the result of extensive investigation of animal models of human diseases. Members of the platform act as potent anti-inflammatory agents, strong iron-chelating agents, and antibiotic agents. These modes of action jointly…